Literature DB >> 19501124

Time course of Newcastle disease virus-induced apoptotic pathways.

P V Ravindra1, Ashok K Tiwari, Barkha Ratta, Manish V Bais, Uttara Chaturvedi, Sudesh Kumar Palia, Bhaskar Sharma, R S Chauhan.   

Abstract

Newcastle disease virus (NDV) causes economically significant Newcastle disease (ND) in almost all birds worldwide. Previous studies have shown that NDV induces caspase dependent apoptotic pathways in infected cells. In the present study, time course induction of apoptotic pathways in Vero cells is described. In NDV-infected cells, caspase-8 activity, percentage of cells showing TRAIL expression was higher at 24h p.i. (post-infection) compared to 48 h p.i. In contrast, caspase-9 activity, efflux of cytochrome c, loss of mitochondrial membrane potential was higher at 48 h compared to 24h p.i. The caspase-3 activity was high both times. Based on these results, it was concluded that at 24h p.i., NDV induces apoptosis through extrinsic apoptotic pathway while at 48 h p.i. predominantly through intrinsic apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501124     DOI: 10.1016/j.virusres.2009.05.012

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  13 in total

Review 1.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

2.  The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo.

Authors:  Muhannad Alkassar; Barbara Gärtner; Klaus Roemer; Friedrich Graesser; Jean Rommelaere; Lars Kaestner; Isabelle Haeckel; Norbert Graf
Journal:  J Neurooncol       Date:  2011-05-24       Impact factor: 4.130

3.  Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells.

Authors:  Mena Mansour; Peter Palese; Dmitriy Zamarin
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

4.  Response of three local chicken ecotypes of Ghana to lentogenic and velogenic Newcastle disease virus challenge.

Authors:  Christopher K Tudeka; George K Aning; Augustine Naazie; Princess K Botchway; Esinam N Amuzu-Aweh; Godwin K Agbenyegah; Ben Enyetornye; Diana Fiadzomor; Perot Saelao; Ying Wang; Terra R Kelly; Rodrigo Gallardo; Jack C M Dekkers; Susan J Lamont; Huaijun Zhou; Boniface B Kayang
Journal:  Trop Anim Health Prod       Date:  2022-03-10       Impact factor: 1.559

5.  Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models.

Authors:  Sara Cuadrado-Castano; Juan Ayllon; Mena Mansour; Janis de la Iglesia-Vicente; Stefan Jordan; Shashank Tripathi; Adolfo García-Sastre; Enrique Villar
Journal:  Mol Cancer Ther       Date:  2015-03-11       Impact factor: 6.261

Review 6.  The therapeutic effect of death: Newcastle disease virus and its antitumor potential.

Authors:  Sara Cuadrado-Castano; Maria T Sanchez-Aparicio; Adolfo García-Sastre; Enrique Villar
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

Review 7.  Oncolytic viruses & their specific targeting to tumour cells.

Authors:  Prafull K Singh; Juwar Doley; G Ravi Kumar; A P Sahoo; Ashok K Tiwari
Journal:  Indian J Med Res       Date:  2012-10       Impact factor: 2.375

8.  Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo.

Authors:  Dongyun He; Lili Sun; Chang Li; Ningning Hu; Yuan Sheng; Zhifei Chen; Xiao Li; Baorong Chi; Ningyi Jin
Journal:  Viruses       Date:  2014-02-18       Impact factor: 5.048

Review 9.  Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodies.

Authors:  Volker Schirrmacher; Philippe Fournier
Journal:  Front Oncol       Date:  2014-09-11       Impact factor: 6.244

10.  Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model.

Authors:  Ying An; Tianyan Liu; Jinjiao He; Hongsong Wu; Rui Chen; Yunye Liu; Yunzhou Wu; Yin Bai; Xiaochen Guo; Qi Zheng; Chang Liu; Jiechao Yin; Deshan Li; Guiping Ren
Journal:  J Biomed Sci       Date:  2016-07-28       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.